The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …

The Gemini Study was a 14‐week, open‐label, noncomparative, office‐based, multicenter
trial to evaluate single‐pill therapy in the treatment of concomitant hypertension and …

Amlodipine/atorvastatin (Caduet®) is a once-daily fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …

Patients with hypertension (HTN) and dyslipidemia (DYS) have increased risk for
cardiovascular disease (CVD). The presence of increasing numbers of CV risk factors has a …

Cardiovascular diseases are the leading cause of death worldwide. Risk factors are rarely
seen individually, and the 2 most common and most frequently associated risk factors are …

Background: This study was a multicenter, randomized, double-blinded, placebo-controlled
phase III clinical trial to investigate the efficacy and safety of an olmesartan/amlodipine …

The aim was to evaluate the efficacy of a single-pill combination of atorvastatin/amlodipine
in patients with arterial hypertension, dyslipidemia and moderate to high cardiovascular risk …

OBJECTIVE To investigate the efficacy and safety of single-pill amlodipine/atorvastatin
therapy for the simultaneous treatment of hypertension (HTN) and dyslipidemia in African …

This retrospective claims database analysis compared two strategies of hypertension
treatment in outpatient, emergency, and inpatient departments: a fixed‐dose combination …